ESR1 and breast cancer: Our study indicated that the ER low positive tumors receiving neoadjuvant chemotherapy showed a pCR rate of 31.8%, which is consistent with previous studies that have described the response to neoadjuvant chemotherapy in ER low positive breast cancers [23, 27, 32, 33].